IFNA1 and infection: These data indicate that the transcomplementation had only affected the initial infection of the first cell which gave rise to a plaque and that the small amount of incoming pUL36 DUB derived from the transcomplemented inoculum enabled the HSV-1 DUB mutant to overcome some IFN-induced, antiviral effector mechanisms, which work to prevent plaque initiation.